Compare IMMP & INDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMMP | INDO |
|---|---|---|
| Founded | 1987 | 2018 |
| Country | Australia | Indonesia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.2M | 69.4M |
| IPO Year | 2012 | 2018 |
| Metric | IMMP | INDO |
|---|---|---|
| Price | $0.36 | $3.75 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | 3.3M | ★ 4.3M |
| Earning Date | 04-23-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $382.75 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.35 | $2.21 |
| 52 Week High | $3.53 | $8.50 |
| Indicator | IMMP | INDO |
|---|---|---|
| Relative Strength Index (RSI) | 13.40 | 43.00 |
| Support Level | N/A | $2.72 |
| Resistance Level | $1.90 | $5.12 |
| Average True Range (ATR) | 0.06 | 0.37 |
| MACD | -0.05 | -0.11 |
| Stochastic Oscillator | 0.28 | 8.42 |
Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-004, TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.
Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. The company is an independent energy company engaged in the oil and gas business and holds two oil and gas assets through its subsidiaries in Indonesia: The Kruh Block and the Citarum Block. It has also identified a potential third exploration block known as the Rangkas area. . Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.